DETERMINATION OF THE CAMPTOTHECIN DERIVATIVES CPT-11 AND SN-38 IN URINE AND SALIVA BY MICELLAR ELECTROKINECTIC CHROMATOGRAPHY

被引:3
|
作者
Marques, F. F. C. [1 ,2 ]
Cunha, A. L. M. C. [1 ]
Sa, A. [1 ]
Aucelio, R. Q. [1 ]
机构
[1] Pontificia Univ Catolica Rio de Janeiro, Dept Quim, BR-22451900 Rio De Janeiro, RJ, Brazil
[2] Univ Fed Fluminense, Dept Quim Analit, Rio De Janeiro, Brazil
关键词
Irinotecan; Micellar electrokinetic capillary chromatography; Normal stacking mode; SN-38; TISSUE-CULTURE MEDIA; LIQUID-CHROMATOGRAPHY; IRINOTECAN; CAPILLARY; PHARMACOKINETICS; METABOLISM; PLASMA; AGENTS;
D O I
10.1080/00032719.2012.677985
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The anti-cancer synthetic drug irinotecan (CPT-11) and its active metabolite SN-38 have been determined by micellar electrokinetic capillary chromatography (MEKC). The detection of the analytes was made at 368 nm and their separation took less than 7 min using a borate buffer (pH 8.8 at 25 mmol L-1) solution containing sodium dodecyl sulfate (45 mmol L-1) and acetonitrile (13.5% v/v). On-line analyte concentration (normal stacking mode) and the use of a highly sensitive cell (Z shaped cell) improved detection limits (at the 10(-8) mol L-1 level). Recovery in fortified human saliva was 108 +/- 5%, in agreement with the result achieved with the reference HPLC method. For the analysis of urine from rats submitted to a single dose of CPT-11 and SN-38, camptothecin was used as internal standard enabling recoveries close to 100% when compared to the results achieved using HPLC.
引用
收藏
页码:1849 / 1861
页数:13
相关论文
共 50 条
  • [41] Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients
    Spinel Karas
    Amy S. Etheridge
    Eleftheria Tsakalozou
    Jacqueline Ramírez
    Erika Cecchin
    Ron H.N. van Schaik
    Giuseppe Toffoli
    Mark J. Ratain
    Ron H.J. Mathijssen
    Alan Forrest
    Robert R. Bies
    Federico Innocenti
    The AAPS Journal, 22
  • [42] Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients
    Karas, Spinel
    Etheridge, Amy S.
    Tsakalozou, Eleftheria
    Ramirez, Jacqueline
    Cecchin, Erika
    van Schaik, Ron H. N.
    Toffoli, Giuseppe
    Ratain, Mark J.
    Mathijssen, Ron H. J.
    Forrest, Alan
    Bies, Robert R.
    Innocenti, Federico
    AAPS JOURNAL, 2020, 22 (03):
  • [43] CYTOTOXICITY OF CPT-11 AND SN-38 FOR GASTROINTESTINAL AND RECURRENT CARCINOMAS CULTURED ON CONTACT-SENSITIVE PLATES
    MATSUOKA, H
    FURUSAWA, M
    TOMODA, H
    SEO, Y
    KONO, A
    TAKEDA, S
    SATO, K
    ANTICANCER RESEARCH, 1994, 14 (2A) : 405 - 409
  • [44] Identification of a new metabolite of CPT-11 (irinotecan). Biosynthesis and activation to SN-38 by human hepatic microsomes
    Haaz, MC
    Dodds, HM
    Riou, JF
    Riche, C
    Rivory, LP
    Robert, J
    ANNALS OF ONCOLOGY, 1998, 9 : 58 - 59
  • [45] Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis
    Gasthuys, Elke
    van Ovost, Judith
    Vande Casteele, Sofie
    Cosyns, Sarah
    Ceelen, Wim
    Van Bocxlaer, Jan
    Vermeulen, An
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2024, 1233
  • [46] An enhanced active efflux of CPT-11 and SN-38 in cisplatin-resistant human KB carcinoma cells
    Chen, ZS
    Sumizawa, T
    Furukawa, T
    Ono, K
    Tani, A
    Komatsu, M
    Akiyama, S
    CANCER LETTERS, 1999, 138 (1-2) : 13 - 22
  • [47] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF IRINOTECAN (CPT-11) AND ITS ACTIVE METABOLITE (SN-38) IN HUMAN PLASMA
    SUMIYOSHI, H
    FUJIWARA, Y
    OHUNE, T
    YAMAOKA, N
    TAMURA, K
    YAMAKIDO, M
    JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 670 (02): : 309 - 316
  • [48] Irinotecan (CPT-11): A preliminary investigation of the relationship between trough concentrations of the active metabolite, SN-38, and toxicity
    Rivory, LP
    Clarke, S
    Bishop, JF
    O'Donnell, A
    Emmett, L
    Findlay, M
    ANNALS OF ONCOLOGY, 1998, 9 : 59 - 59
  • [49] Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection
    deBruijn, P
    Verweij, J
    Loos, WJ
    Nooter, K
    Stoter, G
    Sparreboom, A
    JOURNAL OF CHROMATOGRAPHY B, 1997, 698 (1-2): : 277 - 285
  • [50] Simultaneous determination of irinotecan (CPT-11) and SN-38 in tissue culture media and cancer cells by high performance liquid chromatography: Application to cellular metabolism and accumulation studies
    Hu, Ze-Ping
    Yang, Xiao-Xia
    Chen, Xiao
    Chan, Eli
    Duan, Wei
    Zhou, Shu-Feng
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 850 (1-2): : 575 - 580